Profile
Main Business
Our equity investment business focuses on two major directions: growth-oriented and value-oriented investments. With "tapping into growth potential and identifying great genes" as our core criteria, we precisely screen and evaluate high-quality enterprises that meet our requirements as investment targets through professional industry analysis and in-depth research.
Leveraging a diversified cooperation network that includes securities firms, banks, and professional intermediaries, on the one hand, we precisely identify and expand high-quality investment opportunities in sectors like healthcare and green energy; on the other hand, we connect with listed companies seeking industry transformation, performance enhancement, market expansion, and industrial diversification, and engage in in-depth collaboration to establish industrial M&A funds, achieving efficient matching of resources and demands.
A professional investment research team conducts in-depth research and analysis of entrepreneurial and start-up enterprises, assesses factors such as their technological strength, market potential, and management team to make wise investment decisions and help them achieve rapid growth and value enhancement.
The business development centers around entire process of "screening, evaluation, project approval, and resource allocation". The targeted issuance business for listed companies is a regular operation of our company, with the one-year targeted issuance business of main board listed companies serving as the core focus, complemented by the targeted issuance business of companies listed on the New Third Board, thereby forming a multi-tiered business coverage.
Investment Case
Served as senior partner and executive president of Beijing Jinshang Alliance Investment Company successively; Jiuding Investment Partner and Vice President; Partner of Beijing Hejun Consulting Co., LTD., general Manager of Hejun Medical Business Division;
Mr. Wang ever acted as the accountant and assistant accountant of the assembling plant, Zhuzhou Locomotive Co., Ltd.; the cost group head of the financial department of the company; the vice director of auditing department; the vice director of financial department; the director of auditing department; The vice director and director of the financial department of Xin Ao Group; the vice general manager of the finance center and the general accountant of the combustion engine group; the general accountant of Weiyuan Group and the CFO of Weiyuan Biochemistry; the deputy general manager and general manager of the finance center of Xin Ao Group, as well as the CFO of Xinneng Mining; the vice president of technology of Hubei Jinao and the general manager of Hunan Jiafei New materials; the vice president of Xin Ao Investment Fund Management(Beijing)Co., Ltd. Mr. Wang is experienced in building and completing cost accounting, cost management system and financial management system.
With over seven years of dedicated research and investment expertise in the biopharmaceutical sector.
On December 23, NNFE Investment Fun...
On December 22, NNFE Investment Fun...
On December 19, 2017, NNFE Investme...
Scan QR code for attention
